TNFAIP3 and hepatocellular carcinoma: In the context of the liver, A20 was found to be preferentially expressed in hepatitis B virus-related HCC cell lines and HCC clinical tissues, contributing to cellular proliferation and survival,45, 46 suggesting A20 as a tumor-promoting agent.